Table 8 |
|||
|
Effect of concomitant use of aspirin and NSAIDs among current users as compared to non use of either drug (multiple users of NSAIDs were excluded). |
|||
|
All cases (UGIB/Perforation) |
Controls |
Adjusted RR* |
|
|
(N=2,105) |
(N=11,500) |
(95%CI) |
|
|
|
|||
|
Low-medium-dose NSAIDs only |
83(71/12) |
256 |
2.6 (2.0-3.4) |
|
High-dose# NSAIDs only |
254 (202/52) |
413 |
4.3 (3.6-5.2) |
|
Only aspirin |
221 (201/20) |
767 |
2.1 (1.8-2.5) |
|
Aspirin + low-medium-dose NSAIDs |
9 (6/3) |
34 |
2.2 (1.0-4.6) |
|
Aspirin + high-dose# NSAIDs |
57 (41/16) |
36 |
13.3 (8.5-20.9) |
|
|
|||
|
*Adjusted for sex, age, calendar year, antecedents of gastrointestinal disorders, smoking status, alcohol consumption and use of anticoagulants, steroids, SSRIs and paracetamol. # High-dose NSAIDs: Aceclofenac > 100, acemetacin > 120, diclofenac > 75, etodolac > 400, fenbufen > 900, fenoprofen > 1200, flurbiprofen > 150, ibuprofen > 1200, indometacin > 75, ketoprofen > 100, mefenamic acid > 1000, tiaprofenic acid > 450, azapropazone > 600, meloxicam > 7.5, nabumetone > 1000, naproxen > 500, piroxicam > 10, sulindac > 200, tenoxicam > 10 (all doses in mg). |
|||
|
de Abajo and García Rodríguez BMC Clinical Pharmacology 2001 1:1 doi:10.1186/1472-6904-1-1 |
|||